Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Oct 18, 2006

FDA approves ALLEGRA® (fexofenadine hydrochloride) oral suspension for treatment of seasonal allergy symptoms and chronic idiopathic urticaria

New formulation provides non-impairing symptom relief for pediatric populations
Sep 25, 2006

Sanofi-aventis and UCB sign a co-promotion agreement for Xyzal® in the United States
Sep 19, 2006

Dermik Laboratories announces FDA acceptance of supplemental filing application for SCULPTRA®
Sep 5, 2006

New clinical data show enoxaparin significantly reduced the risk of repeat heart attack and stroke in patients undergoing percutaneous coronary intervention (PCI)
Sep 1, 2006

Preliminary injunction ordered in PLAVIX® patent infringement case - Apotex to halt sales of unauthorized generic

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.